DOCSLIB.ORG

National Heart & Lung Institute

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Heart & Lung Institute NATIONAL HEART & LUNG INSTITUTE, FACULTY OF MEDICINE, IMPERIAL COLLEGE LONDON Academic post at the National Heart & Lung Institute Non-Clinical Lecturer or Clinical/Non-Clinical Senior Lecturer / Reader / Chair 1. THE POST Title of Post: Clinical/Non-Clinical Lecturer / Senior Lecturer / Reader / Chair School/Institute/Department: National Heart & Lung Institute (NHLI) Main site of activity: South Kensington / Hammersmith / Brompton / St Mary’s / Harefield Campus Responsible to: TBC Accountable to: Professor Kim Fox 1.1 Background to the Post This academic post at the National Heart & Lung Institute (NHLI) is for an outstanding clinical or non-clinical lecturer, senior lecturer, reader or professor whose research interests are aligned with the NHLI’s research themes. The institute is a world-leading research centre for investigating the causes and mechanisms underlying diseases of the cardiovascular and respiratory systems, and is an outstanding environment for basic, clinical and translational research. The post holder will have a track record of high impact publications and research grants, and will be able to contribute to the delivery of outstanding research within NHLI. The successful candidate will be working within one of the five divisions of the Institute, and – if clinical – will have close links with Imperial College Healthcare NHS Trust or the Royal Brompton & Harefield NHS Foundation Trust. NB. Details of Imperial College London are found Appendix 1; details of Royal Brompton & Harefield NHS Foundation Trust are found in Appendix 2; details of the Imperial College Healthcare NHS Trust are found in Appendix 3; details of salary and conditions of service are found in Appendix 4. 2. THE NATIONAL HEART & LUNG INSTITUTE 2.1 An Overview The National Heart & Lung Institute is an Institute of the Faculty of Medicine, and its research and academic focus lie in heart and lung disease. Professor Kim Fox is the Head of Institute. NHLI is divided into five Divisions: • Airway Disease • Respiratory Sciences 1 • Genetic Medicine and Population Health • Cardiovascular Science • Myocardial and Vascular Biology The divisions comprise the groupings listed below. Airway Disease o Airway Disease o COPD and Asthma o Pharmacology and Toxicology o Chronic Respiratory Failure and Sleep Respiratory Sciences o Molecular Medicine o Inflammation, Development and Repair o Respiratory Infection Genetic Medicine and Population Health o Gene Therapy o Genomic Medicine o Infection and Immunity o Population Health and Occupational Disease Cardiovascular Science o Myocardial Function o Heart Science o Vascular Science o Physiology and Disease Prevention Myocardial and Vascular Biology o Cardiovascular Genetics o Quantitative Physiology and Genetics o Heart Failure and Arrhythmias o Vascular Biology 2.2 Staffing and Size NHLI comprises 19 individual research sections/units, as listed above, and has over 100 academic staff. These include approximately 70 research-active professors, and encompass the areas of respiratory and cardiovascular science and medicine. The Institute enjoys an annual turnover of about £60 million and has a staff complement of over 450, including both basic and clinical researchers. NHLI is based on five main sites, at the Royal Brompton, St Mary’s, Hammersmith, South Kensington and Harefield campuses. The Institute has close links to the Royal Brompton & 2 Harefield NHS Foundation Trust – which has renewed funding from NIHR for two Biomedical Research Units (Cardiovascular and Respiratory) – and Imperial College Healthcare NHS Trust, containing the new Academic Health Science Centre which holds a major NIHR Biomedical Research Centre. 2.3 Research Activities of the NHLI The National Heart & Lung Institute (NHLI) is a major department of Imperial College’s Faculty of Medicine and is a leading international research centre for investigating the mechanisms underlying many chronic diseases within the cardiovascular and respiratory systems such as asthma, cystic fibrosis and interstitial lung disease. There is a broad spectrum of research from the bench to the bedside to the community within the Institute. As a research centre, NHLI’s main aim is to carry out research, development and education in heart and lung science. The Institute produces in excess of 500 peer-reviewed publications each year. NHLI receives around £30m of new grant awards each year, which includes peer reviewed awards from charities, research councils and research contracts with industry. The department currently holds a portfolio of approximately £175m of research funding. NHLI was highly rated in terms of both quality and number of researchers in the 2014 Research Excellence Framework (REF), with researchers mainly contributing to Unit of Assessment 1 (Clinical Medicine), where Imperial was ranked third by percentage of 4* staff, fourth by grade point average (GPA) and second by research power. 2.4 Teaching Activities of the NHLI NHLI leads two one-year BSc programmes in Cardiovascular and Respiratory Sciences and is responsible for respiratory and cardiovascular elements of the School of Medicine medical degrees. The department’s expanding postgraduate portfolio currently contains five MSc degrees, as well as a number of Short Courses. NHLI also hosts streams of the Faculty of Medicine MRes in Biomedical Research. The Institute offers suitably qualified scientists and clinicians opportunitites to study for doctoral degrees (PhD or MD(Res)). Its current postgraduate research numbers average 180 enrolled research students and fellows who undertake clinical and basic academic research carried out throughout NHLI’s campuses and locations. The successful applicant will be expected to contribute to the teaching activities of the Institute. 2.5 Relationship with other Schools/Institutes/Departments, Faculties and CPGs The post holder will have close links with other sections and divisions within NHLI, as well as with other departments within the Faculty of Medicine and other faculties within Imperial College. Interdisciplinary research is strongly encouraged. 3 3. THE POST – KEY RESULT AREAS, MAIN DUTIES AND RESPONSIBILITIES Lecturer The appointee will be able to demonstrate their ability to produce independent research and will have developed the skills to take a more active role in teaching and supervision. Senior Lecturer The appointee will have extensive professional experience and will be able to demonstrate a reputation in their field based on their achievements in either teaching or research. The appointee will be expected to demonstrate their independence through their body of original research work or record of teaching impact. Reader The appointee will have developed an international reputation based on a track record of research shown to influence their area of research, and be able to consistently demonstrate the ability to attract research income. Professor The appointee will be able to demonstrate a sustained international reputation based on an extensive track record of research with a major influence on their field of research and a significant impact shown, for example through consistent influence on research income. 3.1 Research • To develop a broad range of research within their division. • To, depending on level, direct, lead or contribute to a research area with scientists, clinicians, technicians and students at the highest scientifically rigorous levels. • To supervise, train and mentor scientists, clinicians, technicians and students at the highest scientifically rigorous levels. • To successfully obtain funds and research grants for research and provide encouragement and guidance to junior research staff to do the same. • To manage research projects. • To write reports for submission to research sponsors and to take part in Audit. • To publish research papers in high quality peer reviewed journals. • To attend and present work at national and international conferences. • To develop contacts with other research organisations, both academic and commercial. • To collaborate with and strengthen links with colleagues within the Faculty of Medicine across all schools/institutes/departments (SIDs) and contribute to the work of the Faculty and College. 4 • To collaborate with academic and clinical colleagues to enhance the NHS Trust’s translational research portfolio, at all times meeting the full requirements of Research Governance. • To attend and contribute to research and administrative meetings within the Section and Division. • To attend and contribute to research and administrative meetings within NHLI, as and when requested. • To foster scientific collaborations through organising, attending and contributing to multidisciplinary meetings, both within NHLI and with other appropriate parties at Imperial. • If clinical, it is expected that the post holder will devote the equivalent of between 5 and 8 programmed activities per week to these activities. 3.2 Teaching and Training • To teach and examine courses at all levels – undergraduate, masters and higher research degrees – through lectures, seminars, tutorials, course work, clinical training (where applicable) and personal supervision. • To plan and review own approach to teaching. • To act as a coach and role model through excellent practice and mentoring colleagues. • To undertake the supervision of MD and PhD candidates. • To provide pastoral support for students. • To train junior medical and nursing staff in the clinical setting (where applicable). • To contribute to curriculum
Load more

Recommended publications
  • Issue 180 • 19 July 2007
    reporter www.imperial.ac.uk Issue 180 • 19 July 2007 Centenary Queen bestows new charter for Imperial’s birthday celebrations > centre pages health minister staff party rocks Professor Sir Ara Darzi south kensington appointed to the Roving reporters government capture the day PAGE 3 PAGES 8–9 in brief AHSC news New Paediatric Research Unit declared open The Paediatric Research Unit, the UK’s first unit solely devoted to paediatric clinical research, • Have your say people to ask questions Kensington Town Hall on 10 was officially opened on 9 July. The Unit is run by The twelve-week consulta- and to express their views. July. Delegates considered researchers from Imperial and St Mary’s Hospital, tion on the proposal to A further 80 people packed how to achieve the mission and is based next to the hospital’s paediatric wards create an Academic Health into the joint overview and and goals of the AHSC. in Paddington. Professor John Warner, Chair in Science Centre (AHSC) scrutiny committee meeting Paediatrics, Head of the Department of Paedi- atrics at Imperial and consultant paediatrician will close on 31 July. The at Portcullis House. • AHSC appointments at St Mary’s Hospital, spoke at the opening. He response so far has been The Joint Steering Group explained that researchers should be designing positive, with approximately • Intranet update has agreed that senior posts therapies specifically for children and their 70 per cent of the comments Staff meetings have now in the AHSC will be for the problems, rather than scaling down treatments received supportive of the been held across the integrated organisation that were created for adults.
    [Show full text]
  • Confirmed Minutes of the London Regional Transfusion
    The London Regional Transfusion Committee Confirmed Minutes of the London Regional Transfusion Committee London Blood Transfusion Forum (RTC Business Meeting) held on 14 October 2016 at The Atrium, Royal Free Hospital Present: Abdul Adamu (AA) Whttington Hospital Anita Aggrey (AAG) Barnet General Hospital Shubha Allard (SA) Barts Health/NHSBT Magda Al-Obaidi (MAO) West Middlesex University Hospital Mariam Ammoun (MA) Hammersmith Hospital Namal Bandara (NB) Kings College Hospital Lorraine Barwick (LB) Great Ormond Street Hospital Chetan Bhatt (CB) Whittington Hospital Dilraj Birdee (DB) Hammersmith Hospital Heather Brotherton (HB) Chase Farm Hospital Alison Brownell (AB) Queens Hospital Romford Elaine Carter-Leay (ECL) Queens Hospital Romford Sandeepa Chandarana (SC) Barnet General Hospital Vashira Chiroma (VC) Hammersmith Hospital Gavin Cho (GC) NHSBT Sarah Clark (SC) Royal Free Hospital Michelle Conway (MC) Harefield Hospital Bernadette Cruz (BC) Northwick Park Hospital Helena Day (HD) Harefield Hospital Ciara Donohue (CD) Royal Free Hospital Oluwatola Elegbe (OE) Barts Health Fernando Fegarido (FF) Kings College Hospital Matthew Free (MF) SWL Pathology - St. George’s Hospital Diana Gabriel (DG) Barts Health Champika Gamlath (CG) Kings College Hospital Lisa Gibb (LG) Great Ormond Street Hospital Jan Gordon (JG) Chelsea & Westminster Hospital Christy Green (CG) Royal London Hospital Jane Harris (JH) New Victoria Hospital Amanda Hobson (AH) Royal Free Hospital Dena Howlett (DH) Epsom General Hospital Charmaine Jardiel (CJ) West Middlesex
    [Show full text]
  • Data Protection Learnings from Across the Pond
    Data Protection Learnings from Across the Pond From GDPR to LGPD Okan Kibaroglu, Head of Governance GDPR to LGPD 26/08/2019 Agenda • Your presenter • This is Imperial! • Principles to keep in mind • Our experience, a detailed synopsis; based on “principles” • Lessons Learnt About me About me – Okan Kibaroglu • Born in Turkey in 1966 • BSc and MSc in Computer Science from Bogazici University, Istanbul • Worked at different industries and management levels in IT since 1994 • At Imperial College for 14 years, and Head of Governance for 5 years • Married with three grown up children This is Imperial! 26/08/2019 Imperial College: Our Mission Imperial College London’s mission is to achieve enduring excellence in research and education in science, engineering, medicine and business for the benefit of society. This is Imperial 26/08/2019 Our standing • Times Higher Education World University Rankings 2019: 9th overall, 3rd in UK • Times Higher Education World’s Most International Universities 2019: 9th in the world • QS World University Rankings 2019: 8th in the world • Research Excellence Framework (REF): 1st for high impact research of any UK university • Reuters Europe’s Most innovative universities 2019: 1st in UK, 3rd in Europe • The Guardian University Guide 2019: 1st for Career Prospects This is Imperial! 26/08/2019 History 1851–1890: Building on the Great Exhibition, Prince Albert supported the idea of South Kensington becoming the London Centre for Science and Arts. Constituent Colleges formed. 1907: Imperial College founded by merger of: • City and Guilds College • Royal College of Science • Royal School of Mines 1987: Management School formed (now Imperial College Business School) This is Imperial! North 26/08/2019 West London Imperial Today Hospitals Nine campuses: • South Kensington • White City • Silwood Park • 6x Hospitals Silwood – Charing Cross Park – Chelsea & Westminster – Hammersmith – North West London Hospitals Campus – Royal Brompton – St Mary’s This is Imperial White City – a new era of discovery for Imperial, London and the wider world.
    [Show full text]
  • RBH-CHD Network Annual Report.Pdf
    The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2018/19 Annual Report Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: For reference only Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Link - Contents 1 Contents Page 1 Contents Page .......................................................................................................................................... 2 2 A message from our Clinical Director ................................................................................................... 4 3 RBH-CHD Network Strategic Vision Statement .................................................................................. 5 4 Summary of Achievements Against our Work Plan – 2018/19 ......................................................... 5 5 Research ................................................................................................................................................... 6 5.1 Grants Awarded ................................................................................................................................ 7 5.2 Research Programmes Peer Reviewed Publications ................................................................. 7 5.3 Research Strategy
    [Show full text]
  • Royal Brompton Hospital Nhs Trust
    ROYAL BROMPTON & HAREFIELD NHS FOUNDATION TRUST LOCUM CONSULTANT IN CYSTIC FIBROSIS Applications are invited for the post of Locum Consultant in Cystic Fibrosis six month fixed term contract. The Royal Brompton & Harefield NHS Foundation Trust is seeking to appoint a LOCUM CONSULTANT IN CYSTIC FIBROSIS to be based at the Royal Brompton Hospital. The Trust is a world famous organisation with a proud history in the investigation, treatment and research of lung and heart disease. We are particularly proud of our ability to provide comprehensive specialist care for patients of all ages and their families. The post will be based at The Royal Brompton Hospital and the successful candidate will work closely with the current physicians in the Cystic Fibrosis Unit to lead the cystic fibrosis service, which attracts tertiary referrals from all over the UK. Applicants are required to be fully registered Medical Practitioners and must be on the GMC’s Specialist Register or be eligible for admission to the Register within three months from date of interview for the post. Informal enquiries may be made to Dr Nicholas Simmonds, Consultant in Respiratory Medicine on 0207 351 8997. For an application form and job description, please contact our Medical Recruitment Manager by email on [email protected] or 0207 351 8688 quoting reference number 312-LC-CF-0915 and we will organise for an application pack to be sent out to you. Alternatively, applications can be made via the NHS jobs website www.jobs.nhs.uk We regret that we are unable to contact applicants who are not selected for an interview, therefore if you do not hear from us within three weeks after the closing date, please assume you have not been successful on this occasion.
    [Show full text]
  • Studies of ACE-Inhibition and Nitrate Supplementation
    Augmenting Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: Studies of ACE-inhibition and Nitrate Supplementation Katrina Jane Curtis The Muscle Laboratory, Royal Brompton Hospital National Heart & Lung Institute, Imperial College London Submitted for the degree of Doctor of Philosophy (PhD) Imperial College London 1 Declaration of originality The data present in this thesis are the result of my original work. Where appropriate the contribution made by other persons has been appropriately acknowledged. Statement of contribution Contributions were made by Kawah Li and Professor Hugh Montgomery at University College London, who performed the ACE genotyping. In addition, Magda Minnion and Professor Martin Feelisch at the University of Southampton performed the measurement of the plasma nitrate and nitrite levels. Juliet Polkey provided assistance with the isotime data analysis in the nitrate supplementation work. Victoria Meyrick and Bhavin Mehta led the pulmonary rehabilitation programme at the Royal Brompton Hospital, and the team at Harefield Hospital are also acknowledged for their assistance in this respect. Copyright declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives license. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the license terms of this work. Sources of funding The research in the thesis was funded by the Medical Research Council (grant reference MR/J000620/1) and the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, where it was undertaken.
    [Show full text]
  • FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub áRea
    Ranking Instituciones No Académicas por sub área OCDE 2020 6. Humanidades > 6.03 Filosofía, Ética y Religión PAÍS INSTITUCIÓN RANKING PUNTAJE FRANCE Centre National de la Recherche Scientifique (CNRS) 1 5,000 RUSSIA Russian Academy of Sciences 2 5,000 USA National Institutes of Health (NIH) - USA 3 5,000 RUSSIA Institute of Philosophy, Russian Academy of Sciences 4 5,000 SPAIN Consejo Superior de Investigaciones Cientificas (CSIC) 5 5,000 USA Seattle Children's Hospital 6 5,000 USA NIH Clinical Center (CC) 7 5,000 USA VA Boston Healthcare System 8 5,000 SLOVAKIA Slovak Academy of Sciences 9 5,000 ARGENTINA Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) 10 5,000 SPAIN CSIC - Instituto de Lenguas y Culturas del Mediterraneo y Oriente Proximo (ILC) 11 5,000 NETHERLANDS Erasmus University Medical Center 12 5,000 NETHERLANDS Academic Medical Center Amsterdam 13 5,000 USA Harvard School of Dental Medicine 14 5,000 GERMANY Helmholtz Association 15 5,000 USA University of Illinois Chicago Hospital 16 5,000 USA Mayo Clinic 17 5,000 FRANCE CNRS - Institute for Humanities & Social Sciences (INSHS) 18 5,000 GERMANY Max Planck Society 19 5,000 AUSTRALIA Florey Institute of Neuroscience & Mental Health 20 5,000 USA The World Bank 21 5,000 CZECH REPUBLIC Czech Academy of Sciences 22 5,000 USA NIH National Institute of Environmental Health Sciences (NIEHS) 23 5,000 NETHERLANDS VU UNIVERSITY MEDICAL CENTER 24 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 25 5,000 NETHERLANDS Utrecht University Medical
    [Show full text]
  • What Do Imperial Medicine* Postgraduates Do?
    What do Imperial Medicine* postgraduates do? Graph 1 – Destinations of 2016 graduates Percentage Entered Employment 66% Entered Further Study/Training 30% Seeking Employment 2% Not Available for Employment/Study/Training 2% Graph 2 – Comparison with previous years 2014 2015 2016 Entered Employment 56% 71% 66% Entered Further Study/Training 32% 23% 30% Seeking Employment 5% 3% 2% Not Available for Employment/Study/Training 7% 3% 2% Graph 3 – Sector of employment entered 2014 2015 2016 Agriculture 0.0% 0.6% 0.0% Oil/Mining 0.0% 0.0% 0.0% Manufacture 2.5% 4.1% 3.8% Utilities & Transport 0.0% 0.0% 0.0% Technical Consultancy/R&D 5.8% 2.4% 3.2% IT & Telecommunications 1.7% 2.9% 0.6% Banking/Financial 1.7% 0.0% 1.3% Accountancy 1.7% 0.6% 0.6% Business & Management Consultancy 1.7% 1.8% 0.6% Other Business Activities 5.0% 4.1% 6.4% Public Administration/Defence 1.7% 5.3% 6.4% Education 38.3% 23.5% 23.7% Health/Social Work 36.7% 52.9% 50.0% Others 3.3% 1.8% 3.2% *This data incorporates the Departments of Medicine; the Institute of Clinical Science; Public Health; Surgery & Cancer; and the National Heart and Lung Institute Careers Service www.imperial.ac.uk/careers Postgraduate Taught Courses Examples of employers and occupations for Medicine et al taught postgraduates who entered employment Examples of Employers Examples of Occupations • Academy of Education Development • Academic Clinical Fellow in General Practise • Aintree Hospital • Account Executive • Assemblies of God church • Associate Project Manager • Associate • Associate Scientist •
    [Show full text]
  • VIVOTM Non-Invasive Time Assessment Protocol
    TM VIVO non-invasive Time Assessment Protocol Short Study Title/Acronym: VIVOTM mapping Protocol REC Reference: Insert REC Reference IRAS Reference: 257755 CHIEF INVESTIGATOR: Dr Sabine Ernst, Consultant Cardiologist and Reader in Cardiology, Lead for Electrophysiology Research for the Royal Brompton Hospital Royal Brompton Hospital (RBH) Sydney Street London SW3 6NP Phone: 00442073518612 Email: [email protected] Fax: 00442073518131 SPONSOR REPRESENTATIVE: Mr Patrik Pettersson Royal Brompton and Harefield NHS Foundation Trust (RB&HFT) Royal Brompton Hospital (RBH) Research Office Chelsea Wing, Level 2 Sydney Street London SW3 6NP Phone: 0207 352 8121 ext. 8736 Email: [email protected] Fax: 0207 351 8829 VIVOTM mapping protocol VIVO-RBH01 Revision A – 15th January 2019 Page 1 of 38 Information in this protocol is confidential and should not be disclosed, other than to those directly involved in the execution or the ethical review of the study, without written authorisation from RB&HFT Research Office. Signature Page The Chief Investigator (CI) and the Research Office have discussed and agreed this study protocol. The investigators agree to perform the investigations outlined in this study protocol and to abide by this protocol except in the case of medical emergency that will be notified to the Research Office. The Investigator agrees to conduct the study in compliance with the study protocol and/or any subsequent amendments approved by the Sponsor and HRA, the Data Protection Act (1998), the Trust Information Governance Policy (or other local equivalent as applicable), the Research Governance Framework for Health & Social Care, 2nd Edition (2005), the Sponsor’s SOPs, and any other applicable regulatory requirements.
    [Show full text]
  • The Royal Brompton & Harefield Hospital NHS Foundation Trust
    The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2019 / 20 Annual Business Plan Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: All Document Authors Meeting Chair Meeting Members Network Management Team Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Contents Page Link 1 Contents 1 Contents ................................................................................................................................................................... 2 2 The Brompton Hospital and Congenital Heart Disease ................................................................................... 3 3 The Annual Business Plan .................................................................................................................................... 3 4 Governance & Committee Structure ................................................................................................................... 3 5 RBH-CHD Strategic Vision ................................................................................................................................... 4 6 Operational Delivery Network ..............................................................................................................................
    [Show full text]
  • Environmental Statement (Volume 1)
    Imperial College Consort Reactor Decommissioning Environmental Statement (Volume 1) 121019 December 2014 Consort Reactor Decommissioning Environmental Statement RSK GENERAL NOTES Project No: 121019-01 (00) Title: Consort Reactor Decommissioning Environmental Statement (Volume 1) Client: Imperial College Date: 8th December 2014 Office: Hemel Hempstead Status: Draft Author: Rebecca Cail Technical reviewer: Peter Whipp Signature: Signature: Date: Date: Project manager: Clare Taylor Quality reviewer: Peter Whipp Signature: Signature: Date: Date: RSK Environment (RSK) has prepared this report for the sole use of the client, showing reasonable skill and care, for the intended purposes as stated in the agreement under which this work was completed. The report may not be relied upon by any other party without the express agreement of the client and RSK. No other warranty, expressed or implied, is made as to the professional advice included in this report. Where any data supplied by the client or from other sources have been used, it has been assumed that the information is correct. No responsibility can be accepted by RSK for inaccuracies in the data supplied by any other party. The conclusions and recommendations in this report are based on the assumption that all relevant information has been supplied by those bodies from whom it was requested. No part of this report may be copied or duplicated without the express permission of RSK and the party for whom it was prepared. Where field investigations have been carried out, these have been restricted to a level of detail required to achieve the stated objectives of the work. This work has been undertaken in accordance with the quality management system of RSK Environment.
    [Show full text]
  • Clinical Senior Lecturer JD.Pdf
    About Imperial College London Overview Imperial College London is one of the world’s greatest universities, renowned for its ground- breaking research, talented community of staff, students and alumni and its international reach. With a mission to achieve enduring excellence in research and education in science, engineering, medicine and business for the benefit of society, the College was founded in 1907 in South Kensington, bringing together nineteenth century institutions including the Royal College of Science, Royal School of Mines and City and Guilds College. Today Imperial collaborates extensively with neighbouring institutions, including the Royal College of Art and the Royal College of Music. From its location in this great cultural quarter, Imperial provides one of the world’s best educations in STEM subjects for more than 18,400 students, over half of whom come from overseas, reflecting its status as the UK’s most international university. Imperial has three academic faculties – Engineering, Medicine, and Natural Sciences – and the Imperial College Business School, as well as a significant number of interdisciplinary research centres focusing on challenging world problems. The College’s mission is supported by over 8,000 diverse staff, who collaborate in the UK and internationally, often across disciplines. In 2017-2018 the College had a total turnover of over £1 billion, of which £364.2 million directly supported research through grants and contracts. The College’s 2015-2020 Strategy is built on the foundations that make Imperial a strong academic institution and the talented and inspirational people who make up its community. The College’s success is recognised all over the world, as is evidenced by daily coverage of Imperial discoveries and innovations in the international media and claims many distinguished members, including 14 Nobel laureates, three Fields Medallists, and members of the Royal Society and National Academies.
    [Show full text]